Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heplisav-B 2-dose vs 3-dose in Cirrhosis
NCT04588077Phase 4Recruiting
- Sponsor
- Mercy Medical Center
- Start
- Sep 2020
- Primary completion
- Dec 2028
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Mercy Medical Center. Started Sep 2020; status: recruiting.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT04588077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04588077.